ARA 290 Myths: What It Can’t Promise (An Honest Guide)
If you found ARA 290 while searching for help with nerve pain, this is for you. We sell it, and here’s what it can and can’t promise.
- ARA 290 has shown encouraging results in small clinical studies but has not been proven to cure neuropathy.
- It is investigational and not approved in Canada, the US or Europe.
- It was designed not to boost red blood cells like EPO.
Let’s be straight with you
If you’ve found ARA 290, you’re probably dealing with nerve pain, or you know someone who is, and you’ve gone a long way down the research rabbit hole looking for something that helps. We understand how exhausting that is. We sell ARA 290, and we want to be honest about what it can and can’t promise.
Myth 1: “ARA 290 cures nerve pain”
The truth: ARA 290 (cibinetide) has been tested in a few small clinical studies, including in people with nerve damage linked to sarcoidosis and diabetes. Some results were encouraging. “Encouraging small studies” is not the same as “cures nerve pain,” and it hasn’t been approved for any use.
Myth 2: “It’s approved in Europe or the US”
The truth: It isn’t an approved medicine in Canada, the US or Europe. It’s still an investigational compound.
Myth 3: “It’s basically EPO, so it boosts red blood cells or endurance”
The truth: The whole point of ARA 290 is that it was designed not to do that. Researchers kept the part of EPO linked to tissue protection and removed the part that makes red blood cells. It isn’t an endurance shortcut.
Myth 4: “Small trials mean it’s proven safe”
The truth: Small trials are an early step. They can’t rule out rare side effects or tell you how it behaves over years. That takes much larger studies that haven’t been completed.
What ARA 290 actually is
An 11-amino-acid research peptide derived from EPO, studied for tissue-protective effects through what’s called the innate repair receptor. If you’re living with nerve pain, please keep working with your doctor or a pain clinic. There are real treatments, and they’re worth pursuing. For the buying side, see our ARA 290 Canada guide.
Frequently asked questions
Does ARA 290 cure neuropathy?
No. It has shown some encouraging results in small clinical studies, but it has not been proven to cure neuropathy and is not approved for any use.
Is ARA 290 approved?
No. It is investigational and not approved in Canada, the US or Europe.
Does ARA 290 increase red blood cells like EPO?
It was specifically designed not to. It keeps EPO’s tissue-protective activity without stimulating red blood cell production.
Is ARA 290 the same as cibinetide?
Yes.
The bottom line
ARA 290 is a promising research compound with early human data, and it’s still research. If you’re a researcher, ARA 290 10mg is here, along with our free ARA 290 calculator.
Sold for laboratory research use only. Not for human consumption. Not medical advice.
Every batch we sell is independently third-party tested, with the full Certificate of Analysis published and checkable by lot number.